Letters Section Editor: Stephen J. Lurie,
MD, PhD, Senior Editor.
To the Editor: Epidemiologic studies have suggested
possible atherogenic roles for such pathogens as Chlamydia
pneumoniae, Helicobacter pylori, cytomegalovirus,
and herpes simplex virus.1 However, few
data are available on the relation between hepatitis C virus (HCV) infection
and atherosclerosis.2 With the availability
of more reliable assays, HCV infection is emerging as an extremely common
and insidiously progressive disease. The prevalence of antibodies to HCV (anti-HCV)
in patients with diabetes was reported to be higher than in healthy blood
donors.3 We therefore investigated whether
HCV might have a pathogenic effect in atherosclerosis among patients with
type 2 diabetes.
Fukui M, Kitagawa Y, Nakamura N, Yoshikawa T. Hepatitis C Virus and Atherosclerosis in Patients With Type 2 Diabetes. JAMA. 2003;289(10):1245-1246. doi:10.1001/jama.289.10.1245-a